# Athena Technology Acquisition Corp. II: financial statements, quarterly

ATEK · OTC · CIK 1882198 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/atek.md) · [Financials](/companies/atek/financials.md) · [Filings](/companies/atek/filings.md) · [Insiders](/companies/atek/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/atek/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Income tax | $k | [59.1](/filings/0001213900-25-011305.md) | [(346) d](/filings/0001013762-25-001035.md) | [59.2](/filings/0001213900-25-045958.md) | [41.9](/filings/0001213900-25-078506.md) | [38.6](/filings/0001213900-25-127112.md) | not reported | [1.4](/filings/0001213900-26-057851.md) | [1.4](/filings/0001213900-26-089152.md) | [1.5](/filings/0001213900-25-127112.md) | [0.1 d](/filings/0001213900-26-025927.md) | [0.1](/filings/0001213900-26-057851.md) | [0.1](/filings/0001213900-26-089152.md) |
| Net income | $k | [(548)](/filings/0001213900-25-011305.md) | [82.1 d](/filings/0001013762-25-001035.md) | [(602)](/filings/0001213900-25-127112.md) | [(235)](/filings/0001213900-25-127112.md) | [(315)](/filings/0001213900-25-127112.md) | [(1,497) d](/filings/0001213900-26-025927.md) | [(769)](/filings/0001213900-26-089152.md) | [(699)](/filings/0001213900-26-089152.md) | [508](/filings/0001213900-25-127112.md) | [(311) d](/filings/0001213900-26-025927.md) | [(466)](/filings/0001213900-26-089152.md) | [(409)](/filings/0001213900-26-089152.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.0](/filings/0001213900-25-011305.md) | not reported | not reported | [0.0](/filings/0001213900-25-078506.md) | [0.2](/filings/0001213900-25-127112.md) | [0.1](/filings/0001213900-26-025927.md) | [0.5](/filings/0001213900-25-045958.md) | [0.3](/filings/0001213900-25-078506.md) | [0.5](/filings/0001213900-25-127112.md) | [0.3](/filings/0001213900-26-025927.md) | [0.2](/filings/0001213900-26-057851.md) | [0.0](/filings/0001213900-26-089152.md) |
| Current assets | $m | [0.7](/filings/0001213900-23-088718.md) | [1.9](/filings/0001013762-25-001035.md) | not reported | [0.8](/filings/0001213900-24-093491.md) | [0.7](/filings/0001213900-25-011305.md) | [0.8](/filings/0001213900-26-025927.md) | [1.0](/filings/0001213900-25-045958.md) | [1.0](/filings/0001213900-25-078506.md) | [1.2](/filings/0001213900-25-127112.md) | [1.1](/filings/0001213900-26-089152.md) | [0.8](/filings/0001213900-26-057851.md) | [0.7](/filings/0001213900-26-089152.md) |
| Total assets | $m | [26.0](/filings/0001213900-23-088718.md) | [26.3](/filings/0001013762-25-001035.md) | not reported | [15.5](/filings/0001213900-24-093491.md) | [15.6](/filings/0001213900-25-011305.md) | [4.5](/filings/0001213900-26-025927.md) | [4.7](/filings/0001213900-25-045958.md) | [4.6](/filings/0001213900-25-078506.md) | [1.5](/filings/0001213900-25-127112.md) | [1.4](/filings/0001213900-26-089152.md) | [1.1](/filings/0001213900-26-057851.md) | [0.9](/filings/0001213900-26-089152.md) |
| Current liabilities | $m | [5.0](/filings/0001213900-23-088718.md) | [7.6](/filings/0001013762-25-001035.md) | not reported | [7.9](/filings/0001213900-24-093491.md) | [8.3](/filings/0001213900-25-011305.md) | [10.1](/filings/0001213900-26-025927.md) | [11.0](/filings/0001213900-25-045958.md) | [11.6](/filings/0001213900-25-078506.md) | [8.9](/filings/0001213900-25-127112.md) | [9.1](/filings/0001213900-26-089152.md) | [9.3](/filings/0001213900-26-057851.md) | [9.6](/filings/0001213900-26-089152.md) |
| Total liabilities | $m | [13.9](/filings/0001213900-23-088718.md) | [16.5](/filings/0001013762-25-001035.md) | not reported | [16.8](/filings/0001213900-24-093491.md) | [17.3](/filings/0001213900-25-011305.md) | [19.0](/filings/0001213900-26-025927.md) | [19.9](/filings/0001213900-25-045958.md) | [20.5](/filings/0001213900-25-078506.md) | [17.9](/filings/0001213900-25-127112.md) | [18.0](/filings/0001213900-26-089152.md) | [18.3](/filings/0001213900-26-057851.md) | [18.6](/filings/0001213900-26-089152.md) |
| Shareholders' equity | $m | [(11.9)](/filings/0001213900-25-011305.md) | [(15.0)](/filings/0001213900-26-025927.md) | [(16.1)](/filings/0001213900-25-127112.md) | [(16.5)](/filings/0001213900-25-127112.md) | [(17.1)](/filings/0001213900-25-127112.md) | [(18.9)](/filings/0001213900-26-089152.md) | [(19.4)](/filings/0001213900-26-089152.md) | [(20.2)](/filings/0001213900-26-089152.md) | [(16.7)](/filings/0001213900-25-127112.md) | [(17.0)](/filings/0001213900-26-089152.md) | [(17.5)](/filings/0001213900-26-089152.md) | [(17.9)](/filings/0001213900-26-089152.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.1) d](/filings/0001213900-25-011305.md) | [(0.1) d](/filings/0001013762-25-001035.md) | [(0.2)](/filings/0001213900-25-045958.md) | [(1.5) d](/filings/0001213900-25-078506.md) | [(1.0) d](/filings/0001213900-25-127112.md) | [(0.2) d](/filings/0001213900-26-025927.md) | [(0.1)](/filings/0001213900-26-057851.md) | [(0.4) d](/filings/0001213900-26-089152.md) | [(0.1) d](/filings/0001213900-25-127112.md) | [(0.2) d](/filings/0001213900-26-025927.md) | [(0.2)](/filings/0001213900-26-057851.md) | [(0.1) d](/filings/0001213900-26-089152.md) |
| Share repurchases | $m | [0.0 d](/filings/0001213900-25-011305.md) | [0.0 d](/filings/0001013762-25-001035.md) | not reported | not reported | [0.0 d](/filings/0001213900-25-127112.md) | [11.5 d](/filings/0001213900-26-025927.md) | not reported | not reported | not reported | [0.0 d](/filings/0001213900-26-025927.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.